Jenburkt Pharmaceuticals board to meet for Q2, half-year results

Jenburkt Pharmaceuticals Limited has announced that its board of directors will convene on Tuesday, October 28, 2025. The meeting, scheduled to take place at the company's registered office, is primarily to consider and approve the standalone unaudited financial results for the quarter and half-year period ending September 30, 2025.

This intimation is made in compliance with Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015. The announcement follows a previous letter dated September 22, 2025.

The communication, dated October 3, 2025, was issued by Ashish Shah, sr. vice president & company secretary.